Leonteq Securities’s MacroGenics MGNX Stock Holding History
Bought
Maintained
Sold
Other funds holding MGNX
Leonteq Securities's MGNX Position: Q3 2026 in Review
Leonteq Securities sold out of MacroGenics (MGNX) in Q3 2026, closing a stake of 50,000 shares — an estimated $231K sold.
Leonteq Securities first reported a position in MGNX in Q4 2020 and held it in 10 quarters. The position peaked at $231K in Q2 2026. 131 funds tracked by Wall St. Rank hold MGNX as of Q3 2026.
- Leonteq Securities reported no remaining MacroGenics position as of Q3 2026 after selling out during the quarter.
- Leonteq Securities sold 50,000 MacroGenics shares in Q3 2026, an estimated $231K.
- Leonteq Securities first reported a position in MacroGenics in Q4 2020 and held it in 10 quarters.
- Leonteq Securities's MacroGenics position peaked at $231K in Q2 2026.
- 131 funds tracked by Wall St. Rank held MacroGenics as of Q3 2026.
Based on Leonteq Securities's 13F filing for Q3 2026, filed 29 Oct 2026.